Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Oncimmune (ONC)

Price 12.10p on 23-01-2025 at 17:30:00
Change 0.00p 0%
Buy 12.90p
Sell 12.10p
Buy / Sell ONC Shares
Last Trade: Sell 25,000.00 at 12.10p
Day's Volume: 64,625
Last Close: 12.50p
Open: 12.10p
ISIN: GB00BYQ94H38
Day's Range 12.10p - 12.10p
52wk Range: 9.35p - 30.20p
Market Capitalisation: £14m
VWAP: 12.14968p
Shares in Issue: 112m

Recent Trades History Oncimmune (ONC)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 25,000 12.10p Automatic Execution
16:21:08 - 23-Jan-25
Sell* 25,000 12.18p Ordinary
16:20:36 - 23-Jan-25
Sell* 18 12.10p SI Trade
15:14:36 - 23-Jan-25
Buy* 58 12.90p SI Trade
15:14:36 - 23-Jan-25
Sell* 14,549 12.18p Ordinary
12:25:38 - 23-Jan-25

Share Price History for Oncimmune

Time period:
to
Date Open High Low Close Volume

Share News for Oncimmune

UK shareholder meetings calendar - next 7 days

1st Nov 2024 13:31

Read More

Oncimmune Holdings shares tick up as notes new contracts

31st Oct 2024 14:09

(Alliance News) - Oncimmune Holdings PLC on Thursday highlighted its ability to secure repeat business from "top 10 pharma companies". Read More

UPDATE: Oncimmune raises GBP2.2 million in equity as planned

21st Oct 2024 12:30

Oncimmune Holdings PLC - Leeds, England-based autoantibody profiling research services to pharmaceutical and biotechnology industry to enable delivery of precision medicine - Raises GBP2.2 million from placing of 12.0 million new shares and subscription for 2.3 million more, all at 15 pence. The results of the placing, run as an accelerated bookbuild by brokers Cavendish and Zeus, is in line with plans set out early Friday. Oncimmune also plans a retail share offer of up to 2.0 million shares to raise an additional GBP300,000. Read More

IN BRIEF: Oncimmune converts debt and offers shares in growth push

18th Oct 2024 12:44

Oncimmune Holdings PLC - Nottingham, England-based autoantibody profiling research services to pharmaceutical and biotechnology industry to enable delivery of precision medicine - Recapitalises two-thirds of its debt and launches a new share offer to raise funds to support recent contract wins and prepare for its "next stage of growth". Read More

Oncimmune expects "substantial" revenue growth following contract wins

9th Sep 2024 11:42

(Alliance News) - Oncimmune Holdings PLC said on Monday that it has entered into five new contracts since its last update in May this year, which are set to substantially grow revenue for financial 2025. Read More

FTSE 100 Latest
Value8,565.20
Change20.07

Login to your account

Forgot Password?

Not Registered